Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of HCV Recurrence and Progression Post Liver Transplantation

NCT00701272 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00701272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00701272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of HCV Recurrence and Progression Post Liver Transplantation
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2008
Completion date
December 31, 2014
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, liver transplantation